US Stock MarketDetailed Quotes

Kura Oncology (KURA)

Watchlist

9.260
-0.010-0.11%

Close Apr 24 15:59 ET

9.280
+0.020+0.22%

Post 17:35 ET

821.94MMarket Cap-2.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kura Oncology (KURA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-147.69%-64.06M

-56.43%117.27M

-85.61%-80.63M

32.34%-28.78M

-47.26%-71.93M

207.61%134.32M

884.46%269.13M

-49.65%-43.44M

-66.02%-42.53M

-36.16%-48.84M

Net income from continuing operations

-60.17%-278.67M

-321.50%-81M

-36.23%-74.12M

-30.07%-66.12M

-15.96%-57.43M

-13.99%-173.98M

55.09%-19.22M

-40.94%-54.4M

-36.75%-50.84M

-45.37%-49.53M

Depreciation and amortization

21.70%1.03M

97.55%403K

-21.15%164K

10.89%224K

2.99%241K

-0.12%848K

-4.67%204K

-3.70%208K

-5.16%202K

13.59%234K

Other non cash items

-1.53%515K

-26.43%103K

5.22%141K

8.66%138K

9.02%133K

9.64%523K

17.65%140K

9.84%134K

4.96%127K

6.09%122K

Change In working capital

-35.55%184.44M

-33.47%187.8M

-376.50%-15.86M

951.15%32.55M

-307.81%-20.05M

3,559.97%286.17M

7,505.98%282.26M

13.86%5.74M

-51.20%3.1M

32.41%-4.92M

-Change in receivables

-227.38%-6.74M

1,417.09%27.13M

---31.36M

--44.17M

---46.69M

---2.06M

--0

-Change in inventory

---413K

----

--0

----

-Change in prepaid assets

-132.85%-15.95M

138.63%2.89M

-2,982.07%-10.29M

-404.87%-7.51M

52.54%-1.04M

-249.49%-6.85M

-195.26%-7.48M

-55.38%357K

30.86%2.46M

-3.79%-2.19M

-Change in payables and accrued expense

12.85%17.15M

-81.59%2.34M

124.03%12.72M

15,150.00%7.53M

-73.50%-5.43M

47.19%15.2M

66.13%12.7M

44.35%5.68M

-101.22%-50K

41.69%-3.13M

-Change in other current assets

-771.91%-6.36M

-181.46%-558K

-467.52%-2.88M

-316.88%-1.17M

-858.87%-1.75M

238.25%947K

146.82%685K

-284.06%-508K

70.03%539K

24.86%231K

-Change in other current liabilities

37.60%1.04M

-49.79%118K

41.43%297K

156.25%369K

53.25%259K

453.28%758K

279.03%235K

624.14%210K

336.36%144K

1,200.00%169K

-Change in other working capital

-29.64%195.72M

--156.29M

--15.66M

---10.83M

--34.59M

--278.18M

----

Cash from discontinued investing activities

Operating cash flow

-147.69%-64.06M

-56.43%117.27M

-85.61%-80.63M

32.34%-28.78M

-47.26%-71.93M

207.61%134.32M

884.46%269.13M

-49.65%-43.44M

-66.02%-42.53M

-36.16%-48.84M

Investing cash flow

Cash flow from continuing investing activities

87.11%-13.1M

31.97%-64.6M

106.36%93.97M

36.54%58.94M

-6.37%-101.41M

-753.02%-101.59M

-325.04%-94.96M

432.01%45.54M

193.18%43.17M

-956.65%-95.34M

Net PPE purchase and sale

-1,306.36%-6.64M

-523.92%-2.32M

---2.57M

-9,012.50%-1.46M

-247.62%-292K

-180.95%-472K

-2,225.00%-372K

--0

83.33%-16K

-133.33%-84K

Net investment purchase and sale

93.61%-6.46M

34.16%-62.28M

112.00%96.53M

39.87%60.4M

-6.16%-101.12M

-743.04%-101.12M

-324.07%-94.58M

430.77%45.54M

193.41%43.18M

-953.14%-95.25M

Cash from discontinued investing activities

Investing cash flow

87.11%-13.1M

31.97%-64.6M

106.36%93.97M

36.54%58.94M

-6.37%-101.41M

-753.02%-101.59M

-325.04%-94.96M

432.01%45.54M

193.18%43.17M

-956.65%-95.34M

Financing cash flow

Cash flow from continuing financing activities

-98.84%1.79M

40.82%1.14M

-83.06%515K

-99.90%143K

62.92%154.42M

16.64%806K

2,521.43%2.2M

-96.77%3.04M

148.37M

Net issuance payments of debt

----

--0

----

Net common stock issuance

--0

55.82%145.81M

---1K

--0

--145.81M

Proceeds from stock option exercised by employees

-79.16%1.79M

40.64%1.14M

--0

-83.06%515K

-94.40%143K

613.43%8.6M

16.79%807K

2,521.43%2.2M

605.34%3.04M

--2.56M

Cash from discontinued financing activities

Financing cash flow

-98.84%1.79M

40.82%1.14M

--0

-83.06%515K

-99.90%143K

62.92%154.42M

16.64%806K

2,521.43%2.2M

-96.77%3.04M

--148.37M

Net cash flow

Beginning cash position

501.48%224.46M

92.58%95.29M

81.37%81.95M

23.52%51.27M

501.48%224.46M

-27.96%37.32M

72.16%49.48M

-8.02%45.18M

53.39%41.51M

-27.96%37.32M

Current changes in cash

-140.27%-75.36M

-69.25%53.81M

210.43%13.34M

734.35%30.68M

-4,235.46%-173.19M

1,392.07%187.14M

1,939.89%174.98M

121.08%4.3M

-83.34%3.68M

116.93%4.19M

End cash Position

-33.57%149.1M

92.58%95.29M

81.37%81.95M

23.52%51.27M

501.48%224.46M

72.16%49.48M

-8.02%45.18M

53.39%41.51M

Free cash flow

-152.82%-70.7M

-57.23%114.95M

-91.51%-83.19M

28.94%-30.24M

-47.60%-72.22M

207.08%133.85M

883.01%268.76M

-49.55%-43.44M

-65.46%-42.55M

-36.26%-48.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-147.69%-64.06M	-56.43%117.27M	-85.61%-80.63M	32.34%-28.78M	-47.26%-71.93M	207.61%134.32M	884.46%269.13M	-49.65%-43.44M	-66.02%-42.53M	-36.16%-48.84M
Net income from continuing operations	-60.17%-278.67M	-321.50%-81M	-36.23%-74.12M	-30.07%-66.12M	-15.96%-57.43M	-13.99%-173.98M	55.09%-19.22M	-40.94%-54.4M	-36.75%-50.84M	-45.37%-49.53M
Depreciation and amortization	21.70%1.03M	97.55%403K	-21.15%164K	10.89%224K	2.99%241K	-0.12%848K	-4.67%204K	-3.70%208K	-5.16%202K	13.59%234K
Other non cash items	-1.53%515K	-26.43%103K	5.22%141K	8.66%138K	9.02%133K	9.64%523K	17.65%140K	9.84%134K	4.96%127K	6.09%122K
Change In working capital	-35.55%184.44M	-33.47%187.8M	-376.50%-15.86M	951.15%32.55M	-307.81%-20.05M	3,559.97%286.17M	7,505.98%282.26M	13.86%5.74M	-51.20%3.1M	32.41%-4.92M
-Change in receivables	-227.38%-6.74M	1,417.09%27.13M	---31.36M	--44.17M	---46.69M	---2.06M	---2.06M	--0	--0	--0
-Change in inventory	---413K	----	----	----	----	--0	----	----	----	----
-Change in prepaid assets	-132.85%-15.95M	138.63%2.89M	-2,982.07%-10.29M	-404.87%-7.51M	52.54%-1.04M	-249.49%-6.85M	-195.26%-7.48M	-55.38%357K	30.86%2.46M	-3.79%-2.19M
-Change in payables and accrued expense	12.85%17.15M	-81.59%2.34M	124.03%12.72M	15,150.00%7.53M	-73.50%-5.43M	47.19%15.2M	66.13%12.7M	44.35%5.68M	-101.22%-50K	41.69%-3.13M
-Change in other current assets	-771.91%-6.36M	-181.46%-558K	-467.52%-2.88M	-316.88%-1.17M	-858.87%-1.75M	238.25%947K	146.82%685K	-284.06%-508K	70.03%539K	24.86%231K
-Change in other current liabilities	37.60%1.04M	-49.79%118K	41.43%297K	156.25%369K	53.25%259K	453.28%758K	279.03%235K	624.14%210K	336.36%144K	1,200.00%169K
-Change in other working capital	-29.64%195.72M	--156.29M	--15.66M	---10.83M	--34.59M	--278.18M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-147.69%-64.06M	-56.43%117.27M	-85.61%-80.63M	32.34%-28.78M	-47.26%-71.93M	207.61%134.32M	884.46%269.13M	-49.65%-43.44M	-66.02%-42.53M	-36.16%-48.84M
Investing cash flow
Cash flow from continuing investing activities	87.11%-13.1M	31.97%-64.6M	106.36%93.97M	36.54%58.94M	-6.37%-101.41M	-753.02%-101.59M	-325.04%-94.96M	432.01%45.54M	193.18%43.17M	-956.65%-95.34M
Net PPE purchase and sale	-1,306.36%-6.64M	-523.92%-2.32M	---2.57M	-9,012.50%-1.46M	-247.62%-292K	-180.95%-472K	-2,225.00%-372K	--0	83.33%-16K	-133.33%-84K
Net investment purchase and sale	93.61%-6.46M	34.16%-62.28M	112.00%96.53M	39.87%60.4M	-6.16%-101.12M	-743.04%-101.12M	-324.07%-94.58M	430.77%45.54M	193.41%43.18M	-953.14%-95.25M
Cash from discontinued investing activities
Investing cash flow	87.11%-13.1M	31.97%-64.6M	106.36%93.97M	36.54%58.94M	-6.37%-101.41M	-753.02%-101.59M	-325.04%-94.96M	432.01%45.54M	193.18%43.17M	-956.65%-95.34M
Financing cash flow
Cash flow from continuing financing activities	-98.84%1.79M	40.82%1.14M	0	-83.06%515K	-99.90%143K	62.92%154.42M	16.64%806K	2,521.43%2.2M	-96.77%3.04M	148.37M
Net issuance payments of debt	----	----	----	----	----	--0	----	----	----	----
Net common stock issuance	--0	--0	--0	--0	--0	55.82%145.81M	---1K	--0	--0	--145.81M
Proceeds from stock option exercised by employees	-79.16%1.79M	40.64%1.14M	--0	-83.06%515K	-94.40%143K	613.43%8.6M	16.79%807K	2,521.43%2.2M	605.34%3.04M	--2.56M
Cash from discontinued financing activities
Financing cash flow	-98.84%1.79M	40.82%1.14M	--0	-83.06%515K	-99.90%143K	62.92%154.42M	16.64%806K	2,521.43%2.2M	-96.77%3.04M	--148.37M
Net cash flow
Beginning cash position	501.48%224.46M	92.58%95.29M	81.37%81.95M	23.52%51.27M	501.48%224.46M	-27.96%37.32M	72.16%49.48M	-8.02%45.18M	53.39%41.51M	-27.96%37.32M
Current changes in cash	-140.27%-75.36M	-69.25%53.81M	210.43%13.34M	734.35%30.68M	-4,235.46%-173.19M	1,392.07%187.14M	1,939.89%174.98M	121.08%4.3M	-83.34%3.68M	116.93%4.19M
End cash Position	-33.57%149.1M	-33.57%149.1M	92.58%95.29M	81.37%81.95M	23.52%51.27M	501.48%224.46M	501.48%224.46M	72.16%49.48M	-8.02%45.18M	53.39%41.51M
Free cash flow	-152.82%-70.7M	-57.23%114.95M	-91.51%-83.19M	28.94%-30.24M	-47.60%-72.22M	207.08%133.85M	883.01%268.76M	-49.55%-43.44M	-65.46%-42.55M	-36.26%-48.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm